205 related articles for article (PubMed ID: 1324831)
1. Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Paulsen P; Simon C; Peters O; Hedderich J; Heim P
Chemotherapy; 1992; 38(3):185-90. PubMed ID: 1324831
[TBL] [Abstract][Full Text] [Related]
2. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Pascual A; López-López G; Aragón J; Perea EJ
Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.
Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
Chemotherapy; 1993; 39(1):48-54. PubMed ID: 8444060
[TBL] [Abstract][Full Text] [Related]
4. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.
Milatovic D
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):33-5. PubMed ID: 2154381
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin.
Fietta A; Merlini C; Gialdroni Grassi G
J Chemother; 1997 Feb; 9(1):17-22. PubMed ID: 9106013
[TBL] [Abstract][Full Text] [Related]
6. Penetration of macrolides into human polymorphonuclear leucocytes.
Ishiguro M; Koga H; Kohno S; Hayashi T; Yamaguchi K; Hirota M
J Antimicrob Chemother; 1989 Nov; 24(5):719-29. PubMed ID: 2599996
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes.
Herrera-Insúa I; Pérez P; Ramos C; Martínez P; Gómez-Lus ML; Prieto J
Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):13-6. PubMed ID: 9063667
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
10. Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry.
Wenisch C; Parschalk B; Zedtwitz-Liebenstein K; Weihs A; el Menyawi I; Graninger W
Antimicrob Agents Chemother; 1996 Sep; 40(9):2039-42. PubMed ID: 8878577
[TBL] [Abstract][Full Text] [Related]
11. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin.
Vazifeh D; Abdelghaffar H; Labro MT
Antimicrob Agents Chemother; 2002 May; 46(5):1364-74. PubMed ID: 11959570
[TBL] [Abstract][Full Text] [Related]
12. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
Bahal N; Nahata MC
Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
[TBL] [Abstract][Full Text] [Related]
13. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
[TBL] [Abstract][Full Text] [Related]
14. Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes.
Wildfeuer A; Laufen H; Müller-Wening D; Haferkamp O
Arzneimittelforschung; 1989 Jul; 39(7):755-8. PubMed ID: 2551303
[TBL] [Abstract][Full Text] [Related]
15. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Viluksela M; Vainio PJ; Tuominen RK
J Antimicrob Chemother; 1996 Sep; 38(3):465-73. PubMed ID: 8889721
[TBL] [Abstract][Full Text] [Related]
17. Phagocyte uptake and transport of azithromycin.
McDonald PJ; Pruul H
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):828-33. PubMed ID: 1662626
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin induces in vitro a time-dependent increase in the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes without damaging phagocytes.
Silvestri M; Oddera S; Eftimiadi C; Rossi GA
J Antimicrob Chemother; 1995 Dec; 36(6):941-50. PubMed ID: 8821593
[TBL] [Abstract][Full Text] [Related]
19. An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent.
Anderson R; Joone G; van Rensburg CE
J Antimicrob Chemother; 1988 Dec; 22(6):923-33. PubMed ID: 2977384
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
Guggenbichler JP; Georgopoulos A; Scharrer P; Kobilansky C; Mühlbacher J; Georgopoulos M; Dierich MP
Infection; 1993; 21(4):259-61. PubMed ID: 8225634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
